We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership

News   May 03, 2013

 
Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership
 
 
 

RELATED ARTICLES

Post-heart Attack Antibody Levels May Guide Treatment

News

Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity.

READ MORE

Ancient Enzymes the Catalysts for Discoveries

News

University of Queensland-led research recreating 450 million-year-old enzymes has resulted in a biochemical engineering ‘hack’ which could lead to new drugs, flavours, fragrances and biofuels.

READ MORE

Drug Combo Destroys Chemo-resistant Blood Cancer

News

Researchers have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE